Supernus Pharmaceuticals (SUPN) Times Interest Earned (2011 - 2025)
Supernus Pharmaceuticals' (SUPN) quarterly Times Interest Earned came in at -$0.97 in Q4 2025, down 118.35% year-on-year from $5.27 in Q4 2024, and up 99.93% on a QoQ basis from -$1309.4 in Q3 2025.
Supernus Pharmaceuticals (SUPN) Times Interest Earned (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 15 years of Times Interest Earned data on file, last reported at -$0.97 in Q4 2025.
- On a quarterly basis, Times Interest Earned fell 118.35% year-over-year to -$0.97 in Q4 2025; TTM through Dec 2025 was -$3.86, a 159.79% decrease from a year earlier, with the FY2025 full-year figure at -$0.11, down 108.62% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$0.97, up from -$1309.4 in the prior quarter.
- Over the last five years, Times Interest Earned for SUPN reached as high as $381.73 in Q3 2024 and fell as low as -$1309.4 in Q3 2025.
- Historically, Times Interest Earned has averaged -$44.7 across 5 years, with a median of $1.03 in 2021.
- On a YoY basis, Times Interest Earned climbed as much as 5608.89% in 2023 and fell as far as 12858.2% in 2023.
- Year by year, Times Interest Earned stood at $1.03 in 2021, then surged by 1996.02% to $21.54 in 2022, then slumped by 109.86% to -$2.12 in 2023, then jumped by 348.32% to $5.27 in 2024, then sank by 118.35% to -$0.97 in 2025.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.97 in Q4 2025, -$1309.4 in Q3 2025, and $55.69 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.97 |
| Sep 30, 2025 | -1,309.37 |
| Jun 30, 2025 | 55.69 |
| Mar 31, 2025 | -2.64 |
| Dec 31, 2024 | 5.27 |
| Sep 30, 2024 | 381.73 |
| Jun 30, 2024 | 5.46 |
| Mar 31, 2024 | -0.79 |
| Dec 31, 2023 | -2.12 |
| Jun 30, 2023 | -19.33 |
| Mar 31, 2023 | 1.50 |
| Dec 31, 2022 | 21.54 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 1.03 |
| Sep 30, 2021 | 5.50 |
| Jun 30, 2021 | 6.24 |
| Mar 31, 2021 | 2.17 |
| Dec 31, 2020 | 3.01 |